TB can occur in the stomach as well as in the lungs. It occurs due to the spread of bacteria of lung TB. According to ...

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Fund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, to develop an ultrasensitive ...

A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for ...

A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...

Feb. 25, 2025 — Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria ...

Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 million grant to Fujirebio’s wholly-owned subsidiary, Fluxus, Inc. (Location: Sunnyvale, California), to ...

Dr Abena Jean-Louis is the regional public health expert at WHO AFRO, who is leading efforts to combat tuberculosis and ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).1 ...